Loading...

IsHak Waguih

TitleHealth Sciences Clinical Professor
InstitutionUniversity of California Los Angeles
DepartmentPsychiatry and Biobehavioral Sciences
Address8730 Alden Drive
Los Angeles CA 90048
Phone310-423-3515
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Vanle B, Olcott W, Jimenez J, Bashmi L, Danovitch I, IsHak WW. NMDA antagonists for treating the non-motor symptoms in Parkinson's disease. Transl Psychiatry. 2018 Jun 15; 8(1):117. PMID: 29907742.
      View in: PubMed
    2. Lee CK, Melmed GY, Mann A, Danovitch I, Hedrick R, McGovern DPB, Targan S, Shih D, Vasiliauskas E, IsHak WW, Feldman E. A Multidisciplinary Approach to Biopsychosocial Care for Adults With Inflammatory Bowel Disease: A Pilot Study. Inflamm Bowel Dis. 2018 Jun 15. PMID: 29920581.
      View in: PubMed
    3. Shapiro BB, Hedrick R, Vanle BC, Becker CA, Nguyen C, Underhill DM, Morgan MA, Kopple JD, Danovitch I, IsHak WW. Cryptococcal meningitis in a daily cannabis smoker without evidence of immunodeficiency. BMJ Case Rep. 2018 Jan 26; 2018. PMID: 29374632.
      View in: PubMed
    4. IsHak WW, Steiner AJ, Klimowicz A, Kauzor K, Dang J, Vanle B, Elzahaby C, Reid M, Sumner L, Danovitch I. Major Depression Comorbid with Medical Conditions: Analysis of Quality of Life, Functioning, and Depressive Symptom Severity. Psychopharmacol Bull. 2018 Jan 15; 48(1):8-25. PMID: 29382957.
      View in: PubMed
    5. Clevenger SS, Malhotra D, Dang J, Vanle B, IsHak WW. The role of selective serotonin reuptake inhibitors in preventing relapse of major depressive disorder. Ther Adv Psychopharmacol. 2018 Jan; 8(1):49-58. PMID: 29344343.
      View in: PubMed
    6. Steiner AJ, Boulos N, Wright SM, Mirocha J, Smith K, López E, Gohar SH, Ishak WW. Major Depressive Disorder in Patients With Doctoral Degrees: Patient-reported Depressive Symptom Severity, Functioning, and Quality of Life Before and After Initial Treatment in the STAR*D Study. J Psychiatr Pract. 2017 Sep; 23(5):328-341. PMID: 28961662.
      View in: PubMed
    7. López E, Steiner AJ, Manier K, Shapiro BB, Vanle B, Parisi T, Dang J, Chang T, Ganjian S, Mirocha J, Danovitch I, IsHak WW. Quality of life and functioning of Hispanic patients with Major Depressive Disorder before and after treatment. J Affect Disord. 2018 Jan 01; 225:117-122. PMID: 28826087.
      View in: PubMed
    8. Jaffer KY, Chang T, Vanle B, Dang J, Steiner AJ, Loera N, Abdelmesseh M, Danovitch I, Ishak WW. Trazodone for Insomnia: A Systematic Review. Innov Clin Neurosci. 2017 Jul-Aug; 14(7-8):24-34. PMID: 29552421.
      View in: PubMed
    9. Steiner AJ, Recacho J, Vanle B, Dang J, Wright SM, Miller JS, Kauzor K, Reid M, Bashmi LE, Mirocha J, Danovitch I, IsHak WW. Quality of Life, Functioning, and Depressive Symptom Severity in Older Adults With Major Depressive Disorder Treated With Citalopram in the STAR*D Study. J Clin Psychiatry. 2017 Jul; 78(7):897-903. PMID: 28858443.
      View in: PubMed
    10. Hassamal S, Goldenberg M, Ishak W, Haglund M, Miotto K, Danovitch I. Overcoming Barriers to Initiating Medication-assisted Treatment for Heroin Use Disorder in a General Medical Hospital: A Case Report and Narrative Literature Review. J Psychiatr Pract. 2017 May; 23(3):221-229. PMID: 28492461.
      View in: PubMed
    11. IsHak WW, Pan D, Steiner AJ, Feldman E, Mann A, Mirocha J, Danovitch I, Melmed GY. Patient-Reported Outcomes of Quality of Life, Functioning, and GI/Psychiatric Symptom Severity in Patients with Inflammatory Bowel Disease (IBD). Inflamm Bowel Dis. 2017 05; 23(5):798-803. PMID: 28301432.
      View in: PubMed
    12. Tashjian VC, Mosadeghi S, Howard AR, Lopez M, Dupuy T, Reid M, Martinez B, Ahmed S, Dailey F, Robbins K, Rosen B, Fuller G, Danovitch I, IsHak W, Spiegel B. Virtual Reality for Management of Pain in Hospitalized Patients: Results of a Controlled Trial. JMIR Ment Health. 2017 Mar 29; 4(1):e9. PMID: 28356241.
      View in: PubMed
    13. Goldenberg M, Reid MW, IsHak WW, Danovitch I. The impact of cannabis and cannabinoids for medical conditions on health-related quality of life: A systematic review and meta-analysis. Drug Alcohol Depend. 2017 05 01; 174:80-90. PMID: 28319753.
      View in: PubMed
    14. Dascal J, Reid M, IsHak WW, Spiegel B, Recacho J, Rosen B, Danovitch I. Virtual Reality and Medical Inpatients: A Systematic Review of Randomized, Controlled Trials. Innov Clin Neurosci. 2017 Jan-Feb; 14(1-2):14-21. PMID: 28386517.
      View in: PubMed
    15. IsHak WW, Collison K, Danovitch I, Shek L, Kharazi P, Kim T, Jaffer KY, Naghdechi L, Lopez E, Nuckols T. Screening for depression in hospitalized medical patients. J Hosp Med. 2017 Feb; 12(2):118-125. PMID: 28182810.
      View in: PubMed
    16. Steiner AJ, Boulos N, Mirocha J, Wright SM, Collison KL, IsHak WW. Quality of Life and Functioning in Comorbid Posttraumatic Stress Disorder and Major Depressive Disorder After Treatment With Citalopram Monotherapy. Clin Neuropharmacol. 2017 Jan/Feb; 40(1):16-23. PMID: 27764051.
      View in: PubMed
    17. Danovitch I, Steiner AJ, Kazdan A, Goldenberg M, Haglund M, Mirocha J, Collison K, Vanle B, Dang J, IsHak WW. Analysis of Patient-reported Outcomes of Quality of Life and Functioning Before and After Treatment of Major Depressive Disorder Comorbid With Alcohol Use Disorders. J Addict Med. 2017 Jan/Feb; 11(1):47-54. PMID: 27763941.
      View in: PubMed
    18. Goldenberg M, IsHak WW, Danovitch I. Quality of life and recreational cannabis use. Am J Addict. 2017 Jan; 26(1):8-25. PMID: 28000973.
      View in: PubMed
    19. Goldenberg M, Hassamal S, IsHak WW, Haglund M, Miotto K, Danovitch I. A Call to Action: The Active Role Psychiatrists and the DEA Must Take to Decrease Harm from Psychotropic Drugs Acquired via the Internet. J Clin Psychiatry. 2016 Nov; 77(11):e1495. PMID: 28076677.
      View in: PubMed
    20. IsHak WW, Bonifay W, Collison K, Reid M, Youssef H, Parisi T, Cohen RM, Cai L. The recovery index: A novel approach to measuring recovery and predicting remission in major depressive disorder. J Affect Disord. 2017 01 15; 208:369-374. PMID: 27810720.
      View in: PubMed
    21. IsHak WW, Naghdechi L. Are sertraline, paroxetine and duloxetine the most effective antidepressants for use in depressed adults over 60 years? Evid Based Ment Health. 2016 11; 19(4):e26. PMID: 27388998.
      View in: PubMed
    22. Peselow ED, Clevenger S, IsHak WW. Prophylactic efficacy of lithium, valproic acid, and carbamazepine in the maintenance phase of bipolar disorder: a naturalistic study. Int Clin Psychopharmacol. 2016 07; 31(4):218-23. PMID: 26523730.
      View in: PubMed
    23. IsHak WW, Vilhauer J, Kwock R, Wu F, Gohar S, Collison K, Thomas SN, Naghdechi L, Elashoff D. Examining the Impact of Patient-Reported Hope for Improvement and Patient Satisfaction with Clinician/Treatment on the Outcome of Major Depressive Disorder Treatment. Int Neuropsychiatr Dis J. 2016; 7(2). PMID: 27294164.
      View in: PubMed
    24. Peselow ED, Naghdechi L, Pizano D, IsHak WW. Polypharmacy in Maintenance of Bipolar Disorder. Clin Neuropharmacol. 2016 May-Jun; 39(3):132-4. PMID: 26992156.
      View in: PubMed
    25. IsHak WW, James DM, Mirocha J, Youssef H, Tobia G, Pi S, Collison KL, Cohen RM. Patient-reported functioning in major depressive disorder. Ther Adv Chronic Dis. 2016 May; 7(3):160-9. PMID: 27347363; PMCID: PMC4907070.
    26. López E, Steiner AJ, Hardy DJ, IsHak WW, Anderson WB. Discrepancies between bilinguals' performance on the Spanish and English versions of the WAIS Digit Span task: Cross-cultural implications. Appl Neuropsychol Adult. 2016 Sep-Oct; 23(5):343-52. PMID: 26786894.
      View in: PubMed
    27. Boulos N, Davis MC, Hedrick R, Althauser S, Collison K, IsHak WW. Near-lethal violent suicide attempt in a 15-year old adolescent with no prior psychiatric history following ingestion of 'N-Bomb' drug. Ann Clin Psychiatry. 2015 Aug; 27(3):221-2. PMID: 26247221.
      View in: PubMed
    28. Peselow ED, Pizano DR, IsHak WW. Maintenance treatment for obsessive-compulsive disorder: findings from a naturalistic setting. Ann Clin Psychiatry. 2015 Feb; 27(1):25-32. PMID: 25696778.
      View in: PubMed
    29. Peselow ED, Tobia G, Karamians R, Pizano D, IsHak WW. Prophylactic efficacy of fluoxetine, escitalopram, sertraline, paroxetine, and concomitant psychotherapy in major depressive disorder: outcome after long-term follow-up. Psychiatry Res. 2015 Feb 28; 225(3):680-6. PMID: 25496869.
      View in: PubMed
    30. Goldenberg M, Danovitch I, IsHak WW. Quality of life and smoking. Am J Addict. 2014 Nov-Dec; 23(6):540-62. PMID: 25255868.
      View in: PubMed
    31. IsHak WW, Mirocha J, James D, Tobia G, Vilhauer J, Fakhry H, Pi S, Hanson E, Nashawati R, Peselow ED, Cohen RM. Quality of life in major depressive disorder before/after multiple steps of treatment and one-year follow-up. Acta Psychiatr Scand. 2015 Jan; 131(1):51-60. PMID: 24954156.
      View in: PubMed
    32. IsHak WW, Mirocha J, Pi S, Tobia G, Becker B, Peselow ED, Cohen RM. Patient-reported outcomes before and after treatment of major depressive disorder. Dialogues Clin Neurosci. 2014 Jun; 16(2):171-83. PMID: 25152656; PMCID: PMC4140511.
    33. Kruse JL, Jeffrey JK, Davis MC, Dearlove J, IsHak WW, Brooks JO. Anti-N-methyl-D-aspartate receptor encephalitis: a targeted review of clinical presentation, diagnosis, and approaches to psychopharmacologic management. Ann Clin Psychiatry. 2014 May; 26(2):111-9. PMID: 24501734.
      View in: PubMed
    34. Peselow E, Pi S, Lopez E, Besada A, Ishak WW. The impact of spirituality before and after treatment of major depressive disorder. Innov Clin Neurosci. 2014 Mar; 11(3-4):17-23. PMID: 24800129; PMCID: PMC4008297.
    35. Peselow ED, Karamians R, Lord M, Tobia G, IsHak WW. The discrepancy between patients and informants on clinician-rated measures in major depressive disorder: implications for clinical trials and clinical practice. Int Clin Psychopharmacol. 2014 Mar; 29(2):111-5. PMID: 24216755.
      View in: PubMed
    36. Bensoussan JC, Bolton MA, Pi S, Powell-Hicks AL, Postolova A, Razani B, Reyes K, IsHak WW. Quality of life before and after cosmetic surgery. CNS Spectr. 2014 Aug; 19(4):282-92. PMID: 24354998.
      View in: PubMed
    37. Ishak W, Nikravesh R, Lederer S, Perry R, Ogunyemi D, Bernstein C. Burnout in medical students: a systematic review. Clin Teach. 2013 Aug; 10(4):242-5. PMID: 23834570.
      View in: PubMed
    38. IsHak WW, Mirocha J, Christensen S, Wu F, Kwock R, Behjat J, Pi S, Akopyan A, Peselow ED, Cohen RM, Elashoff D. Patient-reported outcomes of quality of life, functioning, and depressive symptom severity in major depressive disorder comorbid with panic disorder before and after SSRI treatment in the star*d trial. Depress Anxiety. 2014 Aug; 31(8):707-16. PMID: 23861180.
      View in: PubMed
    39. Fakhry H, Goldenberg M, Sayer G, Aye SS, Bagot K, Pi S, Ghazzaoui R, Vo N, Gowrinathan S, Bolton M, IsHak WW. Health-related quality of life in childhood cancer. J Dev Behav Pediatr. 2013 Jul-Aug; 34(6):419-40. PMID: 23838588.
      View in: PubMed
    40. Ishak WW, Greenberg JM, Cohen RM. Predicting relapse in major depressive disorder using patient-reported outcomes of depressive symptom severity, functioning, and quality of life in the Individual Burden of Illness Index for Depression (IBI-D). J Affect Disord. 2013 Oct; 151(1):59-65. PMID: 23790554.
      View in: PubMed
    41. Ramos N, Wystrach C, Bolton M, Shaywitz J, IsHak WW. Delusional disorder, somatic type: olfactory reference syndrome in a patient with delusional trimethylaminuria. J Nerv Ment Dis. 2013 Jun; 201(6):537-8. PMID: 23719328.
      View in: PubMed
    42. IsHak WW, Elbau I, Ismail A, Delaloye S, Ha K, Bolotaulo NI, Nashawati R, Cassmassi B, Wang C. Quality of life in borderline personality disorder. Harv Rev Psychiatry. 2013 May-Jun; 21(3):138-50. PMID: 23660969.
      View in: PubMed
    43. Ishak WW, Christensen S, Sayer G, Ha K, Li N, Miller J, Nguyen JM, Cohen RM. Sexual satisfaction and quality of life in major depressive disorder before and after treatment with citalopram in the STAR*D study. J Clin Psychiatry. 2013 Mar; 74(3):256-61. PMID: 23561231.
      View in: PubMed
    44. Vilhauer JS, Cortes J, Moali N, Chung S, Mirocha J, Ishak WW. Improving Quality of Life for Patients with Major Depressive Disorder by Increasing Hope and Positive Expectations with Future Directed Therapy (FDT). Innov Clin Neurosci. 2013 Mar; 10(3):12-22. PMID: 23630646; PMCID: PMC3638844.
    45. Ishak WW, Greenberg JM, Saah T, Mobaraki S, Fakhry H, Wu QV, Ngor E, Yu F, Cohen RM. Development and validation of the Individual Burden of Illness Index for Major Depressive Disorder (IBI-D). Adm Policy Ment Health. 2013 Mar; 40(2):76-86. PMID: 21969214.
      View in: PubMed
    46. Cohen RM, Greenberg JM, IsHak WW. Incorporating multidimensional patient-reported outcomes of symptom severity, functioning, and quality of life in the Individual Burden of Illness Index for Depression to measure treatment impact and recovery in MDD. JAMA Psychiatry. 2013 Mar; 70(3):343-50. PMID: 23303512.
      View in: PubMed
    47. Macy AS, Theo JN, Kaufmann SC, Ghazzaoui RB, Pawlowski PA, Fakhry HI, Cassmassi BJ, IsHak WW. Quality of life in obsessive compulsive disorder. CNS Spectr. 2013 Feb; 18(1):21-33. PMID: 23279901.
      View in: PubMed
    48. Sy R, Ponton K, De Marco P, Pi S, Ishak WW. Quality of life in anorexia nervosa: a review of the literature. Eat Disord. 2013; 21(3):206-22. PMID: 23600552.
      View in: PubMed
    49. Ugochukwu C, Bagot KS, Delaloye S, Pi S, Vien L, Garvey T, Bolotaulo NI, Kumar N, Ishak WW. The importance of quality of life in patients with alcohol abuse and dependence. Harv Rev Psychiatry. 2013 Jan-Feb; 21(1):1-17. PMID: 23656759.
      View in: PubMed
    50. Papakostas GI, Vitolo OV, Ishak WW, Rapaport MH, Zajecka JM, Kinrys G, Mischoulon D, Lipkin SH, Hails KA, Abrams J, Ward SG, Meisner A, Schoenfeld DA, Shelton RC, Winokur A, Okasha MS, Bari MA, Fava M. A 12-week, randomized, double-blind, placebo-controlled, sequential parallel comparison trial of ziprasidone as monotherapy for major depressive disorder. J Clin Psychiatry. 2012 Dec; 73(12):1541-7. PMID: 23290327.
      View in: PubMed
    51. Ishak WW, Bagot K, Thomas S, Magakian N, Bedwani D, Larson D, Brownstein A, Zaky C. Quality of life in patients suffering from insomnia. Innov Clin Neurosci. 2012 Oct; 9(10):13-26. PMID: 23198273; PMCID: PMC3508958.
    52. IsHak WW, Bolton MA, Bensoussan JC, Dous GV, Nguyen TT, Powell-Hicks AL, Gardner JE, Ponton KM. Quality of life in body dysmorphic disorder. CNS Spectr. 2012 Dec; 17(4):167-75. PMID: 22939280.
      View in: PubMed
    53. Agarwal R, Goldenberg M, Perry R, IsHak WW. The quality of life of adults with attention deficit hyperactivity disorder: a systematic review. Innov Clin Neurosci. 2012 May; 9(5-6):10-21. PMID: 22808445; PMCID: PMC3398685.
    54. Ishak WW, Balayan K, Bresee C, Greenberg JM, Fakhry H, Christensen S, Rapaport MH. A descriptive analysis of quality of life using patient-reported measures in major depressive disorder in a naturalistic outpatient setting. Qual Life Res. 2013 Apr; 22(3):585-96. PMID: 22544416.
      View in: PubMed
    55. Vilhauer JS, Young S, Kealoha C, Borrmann J, IsHak WW, Rapaport MH, Hartoonian N, Mirocha J. Treating major depression by creating positive expectations for the future: a pilot study for the effectiveness of future-directed therapy (FDT) on symptom severity and quality of life. CNS Neurosci Ther. 2012 Feb; 18(2):102-9. PMID: 21615882.
      View in: PubMed
    56. IsHak WW, Brown K, Aye SS, Kahloon M, Mobaraki S, Hanna R. Health-related quality of life in bipolar disorder. Bipolar Disord. 2012 Feb; 14(1):6-18. PMID: 22329468.
      View in: PubMed
    57. Ishak WW, Ugochukwu C, Bagot K, Khalili D, Zaky C. Energy drinks: psychological effects and impact on well-being and quality of life-a literature review. Innov Clin Neurosci. 2012 Jan; 9(1):25-34. PMID: 22347688; PMCID: PMC3280075.
    58. Ishak WW, Ha K, Kapitanski N, Bagot K, Fathy H, Swanson B, Vilhauer J, Balayan K, Bolotaulo NI, Rapaport MH. The impact of psychotherapy, pharmacotherapy, and their combination on quality of life in depression. Harv Rev Psychiatry. 2011 Nov-Dec; 19(6):277-89. PMID: 22098324.
      View in: PubMed
    59. Davidoff J, Christensen S, Khalili DN, Nguyen J, IsHak WW. Quality of life in panic disorder: looking beyond symptom remission. Qual Life Res. 2012 Aug; 21(6):945-59. PMID: 21935739.
      View in: PubMed
    60. Bokarius A, Ha K, Poland R, Bokarius V, Rapaport MH, Ishak WW. Attitude toward humor in patients experiencing depressive symptoms. Innov Clin Neurosci. 2011 Sep; 8(9):20-3. PMID: 22010061; PMCID: PMC3196329.
    61. IsHak WW, Greenberg JM, Balayan K, Kapitanski N, Jeffrey J, Fathy H, Fakhry H, Rapaport MH. Quality of life: the ultimate outcome measure of interventions in major depressive disorder. Harv Rev Psychiatry. 2011 Sep-Oct; 19(5):229-39. PMID: 21916825.
      View in: PubMed
    62. Ishak WW, Bokarius A, Jeffrey JK, Davis MC, Bakhta Y. Disorders of orgasm in women: a literature review of etiology and current treatments. J Sex Med. 2010 Oct; 7(10):3254-68. PMID: 20584112.
      View in: PubMed
    63. Ishak WW, Kahloon M, Fakhry H. Oxytocin role in enhancing well-being: a literature review. J Affect Disord. 2011 Apr; 130(1-2):1-9. PMID: 20584551.
      View in: PubMed
    64. Phan A, Ishak WW, Shen BJ, Fuess J, Philip K, Bresee C, Czer L, Schwarz ER. Persistent sexual dysfunction impairs quality of life after cardiac transplantation. J Sex Med. 2010 Aug; 7(8):2765-73. PMID: 20497304.
      View in: PubMed
    65. Ishak WW, Lederer S, Mandili C, Nikravesh R, Seligman L, Vasa M, Ogunyemi D, Bernstein CA. Burnout during residency training: a literature review. J Grad Med Educ. 2009 Dec; 1(2):236-42. PMID: 21975985; PMCID: PMC2931238.
    66. IsHak WW, Davis M, Jeffrey J, Balayan K, Pechnick RN, Bagot K, Rapaport MH. The role of dopaminergic agents in improving quality of life in major depressive disorder. Curr Psychiatry Rep. 2009 Dec; 11(6):503-8. PMID: 19909674.
      View in: PubMed
    67. IsHak WW, Berman DS, Peters A. Male anorgasmia treated with oxytocin. J Sex Med. 2008 Apr; 5(4):1022-1024. PMID: 18086171.
      View in: PubMed
    68. Ishak WW, Rapaport MH, Gotto JG. The effectiveness of atypical antipsychotic medications in depressive disorders. Curr Psychiatry Rep. 2004 Dec; 6(6):422-4. PMID: 15538989.
      View in: PubMed
    Waguih's Networks
    Concepts
    Derived automatically from this person's publications.
    _
    Co-Authors
    People in Profiles who have published with this person.
    _
    Related Authors
    People who share related concepts with this person.
    _